TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03).

Amar Gajjar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.